Friday, June 24, 2016 1:13:51 PM
IT WAS A PHYSICALLY IMPOSSIBLE TIMELINE that Seymour and Diwan told investors to rely upon, that was contrary to the information the FDA makes publicly available.
It is physically impossible to complete everything required for FDA approval of *ANY* drug within years of Seymour's and Diwan's timelines.
Seymour and Diwan just made up those impossible timelines to trick investors into investing in NNVC based on their lies.
No drug in the history of the FDA has ever been approved within years of what Seymour and Diwan were telling investors.
That's because IT IS PHYSICALLY IMPOSSIBLE to complete all of the requirements for FDA approval of *ANY* drug within those timelines.
The fact that Seymour and Diwan were willfully defrauding the investing public with fictional and impossible timelines is clearly supported by the data the FDA has made publicly available ever since they've had a public website:
http://www.fdareview.org/03_drug_development.php
Seymour and Diwan decided to misinform investors about the minimum amount of time it takes to develop *any* drug, and about the risks in doing so. And not just by a little bit.
When Seymour and Diwan made that choice, they clearly crossed the line. And then they made themselves multimillionaires by doing so, at the expense of NNVC investors.
No ifs, ands, or buts about it.
A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM